By investigating the impact of CXCR1/2 inhibition on TNF-α induced insulin resistance, this study seeks to provide insights into the potential therapeutic targeting of chemokine receptors to improve insulin sensitivity. The gene discussed is CXCR1; the disease is Insulin resistance.